Gossamer Bio Inc (NAS:GOSS)
$ 0.6833 -0.0107 (-1.54%) Market Cap: 154.57 Mil Enterprise Value: 121.66 Mil PE Ratio: 0 PB Ratio: 5.69 GF Score: 38/100

Gossamer Bio Inc at Bank of America Healthcare Conference Transcript

May 11, 2022 / 05:00PM GMT
Release Date Price: $7.21 (+0.70%)
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

Welcome to the second day of the Bank of America Healthcare Conference. I'm Geoff Meacham. I'm the senior biopharma analyst here, and we're thrilled to have Gossamer Bio, and on stage with me is Faheem Hasnain, who is Chairman and CEO; and Richard Aranda, who's not Chief Marketing Officer.

Faheem Hasnain
Gossamer Bio, Inc. - Co-Founder, CEO, President & Chairman

Although I think you would like that.

Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

Yes, exactly.

Richard Aranda
Gossamer Bio, Inc. - Chief Medical Officer

It's an upgrade.

Questions & Answers

Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

Exactly. Let's kick it off then Faheem with sort of a bigger picture. So when you guys founded Gossamer the idea was to have different therapeutic areas and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot